It has added BA.4 and BA.5, sibling lineages of the original Omicron variant, to its list for monitoring. It is already tracking BA.1, BA.1.1 and BA.2 - now globally dominant - as well as BA.3, which has not caused any significant outbreaks.
The WHO said it had begun tracking the newest lineages because of their “additional mutations that need to be further studied to understand their impact on immune escape potential”.
Viruses mutate all the time but only some mutations affect their ability to spread or evade prior immunity from vaccination or infection, or the severity of disease they cause.
For instance, BA.2 now represents nearly 94% of all sequenced cases and is slightly more transmissible than its siblings, but the evidence so far suggests it is no more likely to cause severe disease.
Only a few dozen cases of BA.4 and BA.5 have been reported to the global GISAID database, according to WHO.
The UK’s Health Security Agency said last week BA.4 had been found in South Africa, Denmark, Botswana, Scotland and England from Jan. 10 to March 30.
All the BA.5 cases were in South Africa as of last week, but on April 11 Botswana’s health ministry said it had identified four cases of BA.4 and BA.5, all among people aged 30 to 50 who were fully vaccinated and experiencing mild symptoms.
Reuters Health Information © 2022